These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3409186)

  • 1. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis.
    Horiike S; Taniwaki M; Misawa S; Abe T
    Cancer; 1988 Sep; 62(6):1129-38. PubMed ID: 3409186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome study of 85 patients with myelodysplastic syndrome.
    Musilova J; Michalova K
    Cancer Genet Cytogenet; 1988 Jul; 33(1):39-50. PubMed ID: 3164239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on karyotypic abnormalities and its prognostic significance in Chinese patients with primary myelodysplastic syndromes].
    Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):217-22. PubMed ID: 19731819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
    Bernasconi P; Alessandrino EP; Boni M; Bonfichi M; Morra E; Lazzarino M; Campagnoli C; Astori C
    Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of cytogenetic abnormalities involving chromosomes 5,7 and 8 in myelodysplastic syndromes with fluorescence in situ hybridization and its clinical significance].
    Cai Y; Qin YW; Wang C; Yang J; Yan SK
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):6-10. PubMed ID: 17649717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
    Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
    Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal karyotype abnormalities and clinical progress in the myelodysplastic syndrome.
    Geddes AA; Bowen DT; Jacobs A
    Br J Haematol; 1990 Oct; 76(2):194-202. PubMed ID: 2094322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of continuous karyotyping in myelodysplastic syndromes].
    Lai YY; Qiu JY; Zhang Y; Zhang Y; Shi Y; He Q; Dang H; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2004 Nov; 25(11):645-8. PubMed ID: 15634565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Karyotype analysis of 283 cases of myelodysplastic syndrome].
    Pan HZ; Chen ZM; Lou JY; Xu WL; Jin J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 35(2):143-6. PubMed ID: 16610079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization testing for -5/5q, -7/7q, +8, and del(20q) in primary myelodysplastic syndrome correlates with conventional cytogenetics in the setting of an adequate study.
    Pitchford CW; Hettinga AC; Reichard KK
    Am J Clin Pathol; 2010 Feb; 133(2):260-4. PubMed ID: 20093235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Czechoslovak MDS Cooperative Group.
    Michalova K; Musilova J; Zemanova Z
    Ann Genet; 1991; 34(3-4):212-8. PubMed ID: 1809229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal evolution in primary 5q-syndrome.
    Wong KF; Chan JK; Chu YC; Kwong YL
    Cancer; 1992 Jul; 70(1):100-3. PubMed ID: 1606529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
    Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
    Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis the clinic and cytogenetics of myelodysplastic syndrome].
    Cen L; Zhou M; Zhao YH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):668-9. PubMed ID: 17160950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential observation of clinical and karyotypic evolution in a patient with myelodysplastic syndrome.
    Xue YQ; Guo Y; Lin BJ; Zhang GR; Lu DW; Wang MH; Gu YZ; Gong JX; Wang LX
    Chin Med J (Engl); 1989 Sep; 102(9):689-94. PubMed ID: 2517082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
    Nimer SD
    J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
    Koh Y; Lee HR; Song EY; Kim HK; Kim I; Park S; Park MH; Kim BK; Yoon SS; Lee DS
    Leuk Res; 2010 Oct; 34(10):1344-50. PubMed ID: 20427085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletions of the long arm of chromosome 7 in myeloid disorders: loss of band 7q32 implies worst prognosis.
    Velloso ER; Michaux L; Ferrant A; Hernandez JM; Meeus P; Dierlamm J; Criel A; Louwagie A; Verhoef G; Boogaerts M; Michaux JL; Bosly A; Mecucci C; Van den Berghe H
    Br J Haematol; 1996 Mar; 92(3):574-81. PubMed ID: 8616020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.